Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Bufei Huoxue Capsules in stable COPD with qi deficiency and blood stasis syndrome
CTR20223407Phase 2Completed
- Sponsor
- Lei Yun Shang (Guangdong)
- Start
- Feb 2023
- Countries
- 1
01
Overview
A Phase 2 trial of bufei huoxue capsules in chronic obstructive pulmonary disease (COPD), sponsored by Lei Yun Shang (Guangdong). Started Feb 2023; status: completed.
02
Drugs
bufei huoxue capsules
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20223407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223407.